These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056 [TBL] [Abstract][Full Text] [Related]
23. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261 [TBL] [Abstract][Full Text] [Related]
24. Genetics in twins with Crohn's disease: less pronounced than previously believed? Halfvarson J Inflamm Bowel Dis; 2011 Jan; 17(1):6-12. PubMed ID: 20848478 [TBL] [Abstract][Full Text] [Related]
25. Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease. Yu F; Wang X; Zhao H; Hao Y; Wang W Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625373 [TBL] [Abstract][Full Text] [Related]
26. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease. Braza-Boïls A; Marí-Alexandre J; Molina P; Arnau MA; Barceló-Molina M; Domingo D; Girbes J; Giner J; Martínez-Dolz L; Zorio E Liver Int; 2016 Aug; 36(8):1221-9. PubMed ID: 26901384 [TBL] [Abstract][Full Text] [Related]
28. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Lin HY; Yang YL; Wang PW; Wang FS; Huang YH Cells; 2020 Apr; 9(4):. PubMed ID: 32331364 [TBL] [Abstract][Full Text] [Related]
29. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. Xu Q; Li Y; Shang YF; Wang HL; Yao MX World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466 [TBL] [Abstract][Full Text] [Related]
30. Differences of microRNA expression profiles between monozygotic twins' blood samples. Xiao C; Pan C; Liu E; He H; Liu C; Huang Y; Yi S; Huang D Forensic Sci Int Genet; 2019 Jul; 41():152-158. PubMed ID: 31132533 [TBL] [Abstract][Full Text] [Related]
32. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Matono T; Kato J; Tokunaga S; Sugihara T; Hiramatsu A; Hyogo H; Tobita H; Sato S; Kawanaka M; Hara Y; Hino K; Chayama K; Murawaki Y; Isomoto H PLoS One; 2020; 15(2):e0219412. PubMed ID: 32106257 [TBL] [Abstract][Full Text] [Related]
33. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population. He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471 [TBL] [Abstract][Full Text] [Related]
34. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity. Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP Cell Physiol Biochem; 2016; 39(6):2239-2248. PubMed ID: 27832630 [TBL] [Abstract][Full Text] [Related]
35. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents. Netaji A; Jain V; Gupta AK; Kumar U; Jana M J Pediatr Endocrinol Metab; 2020 Apr; 33(4):473-479. PubMed ID: 32146441 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway. Cai Q; Chen F; Xu F; Wang K; Zhang K; Li G; Chen J; Deng H; He Q Metabolism; 2020 Mar; 104():154140. PubMed ID: 31926204 [TBL] [Abstract][Full Text] [Related]